Moderna stock jumped late Friday on reports the FDA's top vaccine official, Vinay Prasad, will step down amid mounting ...

The drug regulator has cleared Serum Institute to begin Phase III trials for a 2-in-1 covid-flu vaccine while simultaneously approving an Omicron-specific booster, marking a transition toward seasonal ...

Separate VSD analyses confirmed no increased risk of all-cause mortality, cardiac mortality, or non-COVID mortality in the 28 ...

Europe's medicines regulator recommended approval for Moderna's COVID and flu combination vaccine on Friday, putting it on track to become the first single shot to ...

Medical institutions in Korea continued to administer about 14.2 million doses of Covid-19 vaccines even after authorities ...

State health officials say people born between 1957 and 1968 may need additional protection from the measles, even if you ...

For the first study, published yesterday in eClinicalMedicine, an international roster of researchers in the INTERCOVID consortium mined data from 6,527 pregnant women with and without a COVID-19 ...

Booster vaccines reduced the risk of COVID 19–related hospitalisation and death, according to a new study of over 3 million adults who had the autumn ...

In summer 2025, the SARS-CoV-2 JN.1 sublineage became dominant with more resistant variants, such as XFG, LP.8.1, and NB.1.8.1. COVID-19 mRNA boosters were therefore updated for the 2025–2026 season ...

You've seen the headlines about COVID boosters. But what does it all mean for you? Here's how to sort through the science and figure out if and... What you need to know about COVID boosters Millions ...

Moderna is pruning three investigational vaccines from its pipeline, while also securing additional funding, giving the company more financial flexibility as it strives to hit 10% revenue growth in ...